Obstacles cleared for Bertagnolli’s confirmation as NIH director Senate HELP Committee schedules hearing

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several aggressive cuts the White House had proposed for NIH.

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

Over his five decades as a radiation oncologist, Bernie Lewinsky has been collecting the relics of radiotherapy.

NIH ends fetal tissue research—again

NIH will no longer fund scientific research that uses human fetal tissue from elective abortions, a practice that has contributed to the study of cancer, the development of vaccines, and the treatment of other diseases.

NIH agrees to review hundreds of denied or shelved grant applications

Last year, the Trump administration began dismantling, RIFing, and stamping out programs and staff deemed ideological or politically motivated, halting application processes, and stripping funding opportunities.

January 09, 2026

Vol.52 No.1

By Claire Marie Porter

Cancer Policy

Federal judge orders temporary block on 340B drug rebate pilot program

A federal judge has blocked the Health Resources and Services Administration from rolling out a pilot program that would reimburse safety net hospitals that get a discount on drugs through the 340B program via a rebate, as opposed to the status quo of up-front savings. The preliminary injunction was issued on Dec. 29, just a few days before the program was slated to begin on Jan 1.

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Earlier this month, NCI released a new Cancer Center Support Grant Notice of Funding Opportunity. Except for the elimination of the Plan to Enhance Diversity component and lengthening of the Shared Resource write-ups from three to six pages, the guidelines are essentially unchanged.

December 19, 2025

Vol.51 No.46

By Richard J. Jones

Obstacles cleared for Bertagnolli’s confirmation as NIH director

Senate HELP Committee schedules hearing

YOU MAY BE INTERESTED IN

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

NIH ends fetal tissue research—again

NIH agrees to review hundreds of denied or shelved grant applications

Federal judge orders temporary block on 340B drug rebate pilot program

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Renew today!

Subscriber content

Never miss an issue!

Login

Obstacles cleared for Bertagnolli’s confirmation as NIH director

Senate HELP Committee schedules hearing

YOU MAY BE INTERESTED IN

Spending bill passed by the House gives NIH $415M raise, NCI gets $128MLegislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

NIH ends fetal tissue research—again

NIH agrees to review hundreds of denied or shelved grant applications

Federal judge orders temporary block on 340B drug rebate pilot program

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Never miss an issue!

Login

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched